Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Intercell
company
About
Intercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious.
- 251 - 500
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 1998
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Intercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious diseases. It discovers and develops antigens and adjuvants, which are derived from its proprietary technology platforms. The company was founded in 1998 and is headquartered in Vienna, Austria.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$50M
Intercell has raised a total of
$50M
in funding over 2 rounds. Their latest funding was raised on
Jul 18, 2003 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 18, 2003 | Series C | $50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Intercell is funded by 1 investors.
Nomura International
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Nomura International
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
